Viz RV/LV

by Viz.ai  · Based in United States → — The proven AI-powered care coordination platform. Closing the gaps between patients, clinicians, and life-saving treatments with its leading-edge, AI-powered care coordination platform — driven by over 50 advanced, FDA-cleared algorithms.
Emergency Medicine Pulmonology Radiology

Regulatory Status Disclosed

Overview

Viz RV/LV is a software-only device developed by Viz.ai, designed to automatically measure the maximal diameters of the right and left ventricles of the heart from a volumetric CTPA (Computed Tomography Pulmonary Angiogram) acquisition and report their ratio. This artificial intelligence (AI) algorithm accurately identifies the location and measurements of the ventricles and provides users with annotated images to visualize these measurements.

As a seamless component of the broader Viz PE Solution, Viz RV/LV aids in the detection of suspected central and segmental pulmonary emboli. Its integration enables an automated assessment of potential right ventricle dilation, a critical patient risk indicator for pulmonary embolism severity. The overarching Viz.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement
  • Analysis of volumetric CTPA acquisitions
  • AI algorithm for identification and measurement of heart ventricles
  • Provides annotated images showing ventricular measurements
  • Seamless component of the Viz PE Solution for suspected pulmonary embolism detection
  • AI-powered alerts and notifications to care teams
  • High-fidelity mobile DICOM image viewer
  • HIPAA-compliant communication platform for care coordination
  • Integration with EHR and PACS solutions
  • Over 50 FDA-cleared AI algorithms on the Viz.ai One platform

Use Cases

  • Early detection and risk stratification of pulmonary embolism (PE)
  • Expediting treatment decisions for PE patients by assessing right heart strain
  • Facilitating rapid multidisciplinary communication and care coordination for PE
  • Automated assessment of potential right ventricle dilation in PE cases
  • Improving diagnostic acumen and expediting care for acute pulmonary embolism
  • Streamlining clinical workflows and reducing delays in acute care settings

What Physicians Need to Know

ECG/EKG Analysis Capability
The platform analyzes EKGs and includes a publication on 'Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence'.
Echocardiography AI Features
The platform analyzes echocardiograms.
Cardiac CT/MRI Analysis
The platform analyzes CT scans and is part of the Viz Cardio Suite which includes solutions for Hypertrophic Cardiomyopathy, Acute Coronary Syndrome (ACS), and Cardiac Amyloidosis.
Heart Failure Risk Prediction
The Viz Cardio Suite includes solutions for Cardiac Amyloidosis and Hypertrophic Cardiomyopathy, which are conditions related to heart failure.
Coronary Artery Assessment
The Viz Cardio Suite includes solutions for Acute Coronary Syndrome (ACS).
Real-Time Alert Capability
The platform delivers real-time insights and automated assessments to accelerate diagnosis and supports real-time communications, connecting teams within seconds of suspected disease.
Physician Tip

Viz.ai One offers an AI-powered care coordination platform with over 50 FDA-cleared algorithms that analyze medical imaging data, including EKGs, echocardiograms, and CT scans, to provide real-time insights and automated assessments. This can accelerate diagnosis and streamline workflows for conditions such as Hypertrophic Cardiomyopathy, Acute Coronary Syndrome, and Cardiac Amyloidosis. The real-time communication feature allows for rapid team activation upon detection of suspected diseases.

The Viz.ai platform is designed for easy integration and is supported by dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team. It is also involved in pilot programs with Microsoft Cloud for Healthcare.

Details

Category Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Pulmonology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2022-08-29K221100 510(k)Viz RV/LV

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viz RV/LV

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Viz RV/LV.

View all on YouTube

Frequently Asked Questions

The Viz Cardio Suite is an AI-powered solution designed to meet cardiovascular needs, specifically addressing Hypertrophic Cardiomyopathy, Post Acute Stroke, Acute Coronary Syndrome (ACS), and Cardiac Amyloidosis.
Viz.ai emphasizes playing by the rules and delivering excellence, as stated in their 'Quality squared' value. They also provide a Trust Center and various privacy policies, including US Privacy Policy and EU Platform User Privacy Policy, to address data security and compliance.
The provided text does not mention or compare Viz.ai's cardiovascular AI solutions to any alternatives. It focuses solely on describing the features and benefits of the Viz.ai platform and its various suites.
The provided official website text does not explicitly detail any limitations or potential downsides of using the Viz Cardio Suite in clinical practice. It highlights the benefits of accelerating diagnosis and streamlining workflows.
Viz.ai states that its solutions are 'Smart. Simple. Supportive.' and are equipped with dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team to assist with integration and support.
Viz.ai mentions that its platform is 'Clinically validated' and demonstrates 'Real-world performance,' leading to significant time savings and improved patient and economic outcomes. They also refer to 'Clinical Research Publications' and 'Clinical Validation' as available resources.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Viz.ai

Viz AAA
Viz.ai
Cardiology AI
ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Viz ANEURYSM
Viz.ai
Neurology AI
ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.
Viz HCM
Viz.ai
Cardiology AI
ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-15 | First Added: 2026-04-19

Investors who backed Viz RV/LV

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.